Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response

Prophylactic hepatitis C virus (HCV) vaccine trials with human volunteers are pending. There is an important need for immunological end points which correlate with vaccine efficacy and which do not involve invasive procedures, such as liver biopsies. By using a multicomponent DNA priming-protein boo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rollier, C., Depla, E., Drexhage, J. A. R., Verschoor, E. J., Verstrepen, B. E., Fatmi, A., Brinster, C., Fournillier, A., Whelan, J. A., Whelan, M., Jacobs, D., Maertens, G., Inchauspé, G., Heeney, J. L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC303385/
https://ncbi.nlm.nih.gov/pubmed/14671100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.1.187-196.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados